XML 52 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segment Information
 9 Months Ended
Sep. 30, 2014
Segment Reporting [Abstract]  
Business Segment Information
Business Segment Information
We are organized into two operating segments based on product groupings: S&IP and Medical Devices. These operating segments, which are also our reportable global business segments, were determined in accordance with how our executive management develops and executes global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes restructuring charges, transaction costs related to the Spin-off, and other income and expense, net.
The principal sources of revenue in each global business segment are described below:
•
S&IP provides healthcare supplies and solutions that target the prevention and management of healthcare associated infections. This segment has recognized brands across its portfolio of product offerings, including sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. This business is also a global leader in education to prevent healthcare associated infections.
•
Medical Devices provides a portfolio of innovative product offerings focused on pain management and respiratory and digestive health to improve patient outcomes and reduce the cost of care. These products include post-operative pain management solutions, minimally invasive interventional or chronic pain therapies, closed airway suction systems and enteral feeding tubes.
Information concerning unaudited combined operations by business segment is presented in the following table:
 
Three Months Ended
September 30
 
 
 
Nine Months Ended
September 30
 
 
 
2014
 
2013
 
Change
 
2014
 
2013
 
Change
NET SALES
 
 
 
 
 
 
 
 
 
 
 
Surgical and Infection Prevention
$
279.2

 
$
287.0

 
-2.7
 %
 
$
840.2

 
$
860.1

 
-2.3
 %
Medical Devices
122.5

 
126.2

 
-2.9
 %
 
373.5

 
366.8

 
1.8
 %
Corporate & Other
6.8

 
6.3

 
7.9
 %
 
19.0

 
19.3

 
-1.6
 %
COMBINED TOTAL NET SALES
$
408.5

 
$
419.5

 
-2.6
 %
 
$
1,232.7

 
$
1,246.2

 
-1.1
 %
 
 
 
 
 
 
 
 
 
 
 
 
OPERATING PROFIT
 
 
 
 
 
 
 
 
 
 
 
Surgical and Infection Prevention
$
36.8

 
$
45.2

 
-18.6
 %
 
$
118.1

 
$
113.0

 
4.5
 %
Medical Devices
20.4

 
28.0

 
-27.1
 %
 
76.6

 
63.4

 
20.8
 %
Corporate & Other(a)
(44.8
)
 
(3.1
)
 
N.M.

 
(126.8
)
 
(10.6
)
 
N.M.

Other (income) and expense, net
(0.7
)
 
(0.2
)
 
N.M.

 
(2.4
)
 
(1.9
)
 
N.M.

COMBINED TOTAL OPERATING PROFIT
$
13.1

 
$
70.3

 
-81.4
 %
 
$
70.3

 
$
167.7

 
-58.1
 %
N.M. - Not Meaningful
(a)
Corporate & Other for the three and nine months ended September 30, 2014 includes $6 and $55, respectively, associated with Manufacturing Footprint Strategic Changes related to the S&IP business (see Note 3) and $35 and $61, respectively, of transaction costs associated with the Spin-off.